NCT00010842View on ClinicalTrials.gov

Natural Antioxidants in the Treatment of Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1999

Study Completion Date

December 31, 2004

Conditions
Multiple Sclerosis
Interventions
DRUG

Ginkgo biloba

DRUG

Alpha-lipoic acid

DRUG

Vitamin E/Selenium

DRUG

Essential fatty acids

Trial Locations (1)

97207

Oregon Health Sciences University, Portland

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00010842 - Natural Antioxidants in the Treatment of Multiple Sclerosis | Biotech Hunter | Biotech Hunter